SCHEMBL13486385

SCHEMBL13486385

c1ccc(-c2c3ccc(-c4ccc(-c5cn6ccccc6n5)cc4)cc3c(-c3ccccc3)c3ccc(-c4ccc(-c5cn6ccccc6n5)cc4)cc23)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 11/20 0.57
NPC1 O15118 10/20 0.57
KDM4E B2RXH2 9/20 0.57
POLB P06746 1/20 0.57
GFER P55789 3/20 0.56
ALDH1A1 P00352 8/20 0.54
ALDH1A3 P47895 3/20 0.54
ALDH1A2 O94788 1/20 0.54
PKM P14618 5/20 0.53
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
EPHX2 P34913 1/20 0.53
GAA P10253 1/20 0.53
MIF P14174 1/20 0.53
HDAC6 Q9UBN7 1/20 0.51
SMN1; SMN2 Q16637 5/20 0.50
MAPK1 P28482 3/20 0.50
PTGS1 P23219 1/20 0.50
PTGS2 P35354 1/20 0.50
MAPT P10636 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23784951 0.99 RAB9A (0.56) RAB9ANPC1KDM4EPOLBGFER
SCHEMBL10353300 0.99 RAB9A (0.56) RAB9ANPC1KDM4EPOLBGFER
SCHEMBL971632 0.90 RAB9A (0.65) RAB9ANPC1KDM4EPOLBGFER
SCHEMBL13553118 0.90 RAB9A (0.55) RAB9ANPC1KDM4EPOLBGFER
SCHEMBL971874 0.89 RAB9A (0.57) RAB9ANPC1KDM4EPOLBGFER
SCHEMBL13454308 0.89 RAB9A (0.63) RAB9ANPC1KDM4EPOLBGFER
SCHEMBL18999385 0.88 RAB9A (0.53) RAB9ANPC1KDM4EPOLBGFER
SCHEMBL13553109 0.88 RAB9A (0.53) RAB9ANPC1KDM4EPOLBGFER
SCHEMBL10353272 0.87 RAB9A (0.52) RAB9ANPC1KDM4EPOLBGFER
SCHEMBL13454281 0.87 RAB9A (0.69) RAB9ANPC1KDM4EPOLBGFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1925618-B1 Imidazopyridine-based compounds and organic light emitting diode including organic layer comprising the imidazopyridine-based compounds SAMSUNG DISPLAY CO LTD (KR) 2013-03-13 EP disclosed
US-8343638-B2 Organic light emitting diode including light-efficiency-improvement layer SAMSUNG DISPLAY CO., LTD. (KR) 2013-01-01 US disclosed
US-8343638-B2 Organic light emitting diode including light-efficiency-improvement layer SAMSUNG DISPLAY CO., LTD. (KR) 2013-01-01 US disclosed
US-20100039029-A1 Organic Light Emitting Diode Including Light-Efficiency-Improvement Layer SAMSUNG DISPLAY CO., LTD. (KR) 2010-02-18 US disclosed
US-20100039029-A1 Organic Light Emitting Diode Including Light-Efficiency-Improvement Layer SAMSUNG DISPLAY CO., LTD. (KR) 2010-02-18 US disclosed
US-7622584-B2 Imidazopyridine-based compound and organic light emitting diode including organic layer comprising the imidazopyridine-based compound SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2009-11-24 US disclosed
US-7622584-B2 Imidazopyridine-based compound and organic light emitting diode including organic layer comprising the imidazopyridine-based compound SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2009-11-24 US disclosed
US-20080125593-A1 IMIDAZOPYRIDINE-BASED COMPOUND AND ORGANIC LIGHT EMITTING DIODE INCLUDING ORGANIC LAYER COMPRISING THE IMIDAZOPYRIDINE-BASED COMPOUND SAMSUNG DISPLAY CO., LTD. (KR) 2008-05-29 US disclosed
US-20080125593-A1 IMIDAZOPYRIDINE-BASED COMPOUND AND ORGANIC LIGHT EMITTING DIODE INCLUDING ORGANIC LAYER COMPRISING THE IMIDAZOPYRIDINE-BASED COMPOUND SAMSUNG DISPLAY CO., LTD. (KR) 2008-05-29 US disclosed
EP-1925618-A1 Imidazopyridine-based compounds and organic light emitting diode including organic layer comprising the imidazopyridine-based compounds Samsung SDI Co., Ltd. (KR) 2008-05-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080125593-A1 IMIDAZOPYRIDINE-BASED COMPOUND AND ORGANIC LIGHT EMITTING DIODE INCLUDING ORGANIC LAYER COMPRISING THE IMIDAZOPYRIDINE-BASED COMPOUND OCIAD1, OCIAD2, OPRD1 RAB9A 2560/4885NPC1 2550/4885KDM4E 1543/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.